JPRN-UMIN000025252已完成未知
Potassium-competitive acid blocker-based third-line triple therapy in Helicobacter Pylori eradication - Potassium-competitive acid blocker-based third-line triple therapy in Helicobacter Pylori eradication
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •< 20 years old Patients with severe heart desease, renal dysfunction or liver dysfunction Patients with allergy for 3rd-eradication drugs Patients using anti-coagulation or anti-platelet drugs Pregnants or patient who want pregnancy
研究者
相似试验
尚未招募
2 期
Efficacy of Vonoprazan in Management of Post Endoscopic Variceal Ligation UlcerDigestive SystemPACTR202207793488326General Organization for Teaching Hospitals and Institutes300
招募中
不适用
Potassium-Competitive Acid Blocker versus pROton-Pump Inhibitor for GastroproTECTion Strategies In Patients at High Bleeding Risk Receiving Antithrombotic TherapyDiseases of the circulatory systemKCT0008146Asan Medical Center3,100
尚未招募
不适用
Multikinase Inhibitor (Tyrosine and Serine/Threonine Kinase Inhibitor) for the Treatment of Severe Pulmonary Arterial Hypertensiopulmonary arterial hypertensionJPRN-UMIN000001709Medical Education Center, School of Medicine, Keio University10
尚未招募
Unknown
Efficacy of prophylactic potassium-competitive acid blockers after catheter ablation for atrial fibrillatioKCT0009272The Catholic University of Korea, Seoul St. Mary's Hospital60
已完成
1 期
Approved calcium channel blocker in the treatment of fibrodysplasia ossificans progressiva (FOP)fibrodysplasia ossificans progressivaJPRN-UMIN000019348agoya University Graduate School of Medicine5